EDRH
REGN icon

Edmond de Rothschild Holding’s Regeneron Pharmaceuticals REGN Stock Holding History

Edmond de Rothschild Holding’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,400
Closed -$123K – 710
2024
Q1 		$123K Buy
+3,400
New +$3.23M ﹤0.01% 485

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Edmond de Rothschild Holding's REGN Position: Q2 2025 in Review

Edmond de Rothschild Holding sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 34 shares — an estimated $21.6K sold.

Edmond de Rothschild Holding first reported a position in REGN in Q2 2015 and held it in 40 quarters. The position peaked at $10.9M in Q4 2015. 1,203 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Edmond de Rothschild Holding reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 34 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $21.6K.
  • Edmond de Rothschild Holding first reported a position in Regeneron Pharmaceuticals in Q2 2015 and held it in 40 quarters.
  • Edmond de Rothschild Holding's Regeneron Pharmaceuticals position peaked at $10.9M in Q4 2015.
  • 1,203 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2025, filed 12 Aug 2025.